DR REDDYS LABS LTD's ticker is RDY and the CUSIP is 256135203. A total of 188 filers reported holding DR REDDYS LABS LTD in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $444,953 | +5.8% | 6,654 | -0.2% | 0.02% | +7.1% |
| Q2 2023 | $420,628 | +22.3% | 6,665 | +10.4% | 0.01% | +16.7% |
| Q1 2023 | $343,800 | +3.5% | 6,039 | -5.9% | 0.01% | 0.0% |
| Q4 2022 | $332,132 | +18.2% | 6,418 | +19.4% | 0.01% | +9.1% |
| Q3 2022 | $281,000 | -30.6% | 5,376 | -26.4% | 0.01% | -26.7% |
| Q2 2022 | $405,000 | +23.1% | 7,304 | +23.9% | 0.02% | +36.4% |
| Q1 2022 | $329,000 | +42.4% | 5,896 | +87.5% | 0.01% | +22.2% |
| Q2 2021 | $231,000 | +138.1% | 3,144 | +72.0% | 0.01% | +80.0% |
| Q2 2020 | $97,000 | +288.0% | 1,828 | +177.8% | 0.01% | +400.0% |
| Q3 2019 | $25,000 | +25.0% | 658 | +21.6% | 0.00% | 0.0% |
| Q2 2019 | $20,000 | +17.6% | 541 | +28.2% | 0.00% | 0.0% |
| Q1 2019 | $17,000 | +142.9% | 422 | +135.8% | 0.00% | 0.0% |
| Q4 2018 | $7,000 | +16.7% | 179 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Segantii Capital Management Ltd | 224,276 | $10,460,000 | 2.84% |
| Hansberger Growth Investors, LP | 74,293 | $3,449,000 | 2.60% |
| Community Financial Services Group, LLC | 95,548 | $4,436,000 | 2.10% |
| COMMONWEALTH BANK OF AUSTRALIA | 3,142,150 | $145,859,000 | 1.73% |
| THOMAS WHITE INTERNATIONAL LTD | 179,429 | $8,329,000 | 1.20% |
| LMR Partners LLP | 221,754 | $10,294,000 | 0.98% |
| Dalton Investments, Inc. | 51,600 | $2,395,000 | 0.97% |
| Sivik Global Healthcare LLC | 30,000 | $1,393,000 | 0.70% |
| NINE MASTS CAPITAL Ltd | 55,800 | $2,613,000 | 0.52% |
| Fisher Asset Management, LLC | 5,696,909 | $264,451,000 | 0.47% |